Literature DB >> 20036394

Factors affecting number of lymph nodes harvested in colorectal cancer.

Anna Mary Leung1, Andrew W Scharf, Huan Nguyen Vu.   

Abstract

BACKGROUND: Lymph node involvement is a highly important prognostic factor in colorectal cancer staging. Examination of a minimum of 12 nodes is recommended for accurate staging. The purpose of this study was to identify factors affecting the number of lymph nodes harvested in colorectal cancer specimens.
MATERIALS AND METHODS: Retrospective review of all patients undergoing colectomy for colorectal cancer at our VA hospital from 2002 to 2007 was done. Statistical analysis was done using univariate as well as multivariate analysis. One hundred eighty-three patients were analyzed.
RESULTS: Average number of nodes retrieved was 14.9 with 92 (51%) containing fewer than 12 lymph nodes. Median number of nodes was 11. The only two factors found to have an effect on nodes harvested were pathologist P<0.05 and surgeon experience P=0.01. Factors not found to have an impact on number of nodes harvested were age of patient, previous operation, T stage of tumor, type of colectomy, bowel prep, laparoscopic versus open technique, or BMI. Multivariate analysis confirmed pathologist and surgeon experience as independent factors associated with number of nodes retrieved P<0.05.
CONCLUSIONS: Operating surgeon and examining pathologist were the only factors found to have a significant impact on number of nodes harvested. Meticulous dissection both in and outside of the operating room are indicated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20036394     DOI: 10.1016/j.jss.2009.09.001

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

1.  Lymph node count in colorectal cancer - do we have the final answer?

Authors:  Laszlo Igali
Journal:  J Gastrointest Oncol       Date:  2012-12

2.  Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer.

Authors:  Wenqi Bai; Yueqin Wu; Ping Zhang; Yanfeng Xi
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Evaluating Dissemination of Adequate Lymphadenectomy for Gastric Cancer in the USA.

Authors:  Anthony M Villano; Alexander Zeymo; James McDermott; Andrew Crocker; Jay Zeck; Kitty S Chan; Nawar Shara; Sunnie Kim; Waddah B Al-Refaie
Journal:  J Gastrointest Surg       Date:  2019-02-20       Impact factor: 3.452

4.  Comparison of different lymph node staging systems for predicting prognosis in patients with colon cancer who have undergone surgical resection.

Authors:  Anna Madej-Mierzwa; Mariusz Szajewski; Wiesław Janusz Kruszewski
Journal:  Oncol Lett       Date:  2022-04-14       Impact factor: 2.967

Review 5.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

6.  Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon.

Authors:  Kim F Rhoads; Leland K Ackerson; Justine V Ngo; Florette K Gray-Hazard; S V Subramanian; R Adams Dudley
Journal:  Med Care       Date:  2013-12       Impact factor: 2.983

Review 7.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

8.  Variation in Adequate Lymph Node Yield for Gastric, Lung, and Bladder Cancer: Attributable to the Surgeon, Pathologist, or Hospital?

Authors:  Christopher T Aquina; Matthew Truong; Carla F Justiniano; Roma Kaur; Zhaomin Xu; Francis P Boscoe; Maria J Schymura; Adan Z Becerra
Journal:  Ann Surg Oncol       Date:  2020-05-06       Impact factor: 5.344

9.  Clinical and pathologic factors affecting lymph node yields in colorectal cancer.

Authors:  Ta-Wen Hsu; Hsin-Ju Lu; Chang-Kuo Wei; Wen-Yao Yin; Chun-Ming Chang; Wen-Yen Chiou; Moon-Sing Lee; Hon-Yi Lin; Yu-Chieh Su; Shih-Kai Hung
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.